In one of the first studies that investigated the content of NDEVs as biomarkers, it was shown that p‐serine 312‐IRS‐1 and p‐pan‐tyrosine‐IRS1 were found in AD patients’ NDEVs and were significantly higher than in DM2 or FTD patient EVs. Here, IRS1 is linked to Alzheimer disease.